相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Roxadustat (FG-4592) protects against ischaemia/reperfusion-induced acute kidney injury through inhibiting the mitochondrial damage pathway in mice
Mei Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
Qiyan Zheng et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy
Qisheng Lin et al.
AUTOPHAGY (2021)
Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016-2020)
Hyun Seung Ban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability
Mengqiu Wu et al.
CLINICAL SCIENCE (2021)
L-Leucine Improves Metabolic Disorders in Mice With in-utero Cigarette Smoke Exposure
Yunxin Zeng et al.
FRONTIERS IN PHYSIOLOGY (2021)
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS
Jing Yu et al.
JCI INSIGHT (2021)
Transcription-Based Multidimensional Regulation of Fatty Acid Metabolism by HIF1α in Renal Tubules
Wenju Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation
A-Feng Miao et al.
RENAL FAILURE (2021)
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia
Kaijun Su et al.
DRUG DISCOVERY TODAY (2020)
Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies
B. Toczylowska et al.
MOLECULAR NEUROBIOLOGY (2020)
A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
Zhipeng Yan et al.
FRONTIERS IN MEDICINE (2020)
IGFBP5 suppresses oleate-induced intramyocellular lipids deposition and enhances insulin signaling
Aoqi Xiang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease
M. Canadas-Garre et al.
JOURNAL OF PROTEOMICS (2019)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury
Yunwen Yang et al.
CLINICAL SCIENCE (2018)
Parenteral Succinate Reduces Systemic ROS Production in Septic Rats, but It Does Not Reduce Creatinine Levels
Sebastian P. Chapela et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Tryptophan as a surrogate prognostic marker for diabetic nephropathy
Chien-An Chou et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
The role of succinate and ROS in reperfusion injury - A critical appraisal
Tatyana N. Andrienko et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression
Laura Gonzalez-Calero et al.
TRANSLATIONAL RESEARCH (2016)
L-Arginine and its metabolites in kidney and cardiovascular disease
Ada Popolo et al.
AMINO ACIDS (2014)
L-Leucine Supplementation Worsens the Adiposity of Already Obese Rats by Promoting a Hypothalamic Pattern of Gene Expression that Favors Fat Accumulation
Thais T. Zampieri et al.
NUTRIENTS (2014)
Hypoxia-Inducible Factor-1α in Vascular Smooth Muscle Regulates Blood Pressure Homeostasis Through a Peroxisome Proliferator-Activated Receptor-γ-Angiotensin II Receptor Type 1 Axis
Yan Huang et al.
HYPERTENSION (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Global metabolic profiling of animal and human tissues via UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2013)
Recent advances involving the renin-angiotensin system
Steven D. Crowley et al.
EXPERIMENTAL CELL RESEARCH (2012)
AT1A Angiotensin Receptors in the Renal Proximal Tubule Regulate Blood Pressure
Susan B. Gurley et al.
CELL METABOLISM (2011)
The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
Michele M. Hickey et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Development of a Robust and Repeatable UPLC-MS Method for the Long-Term Metabolomic Study of Human Serum
Eva Zelena et al.
ANALYTICAL CHEMISTRY (2009)
Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade
Ikuo Kimura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2α mutation
Daniel P. Gale et al.
BLOOD (2008)
Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet
Laura K. Stewart et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs
Andrew D. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Urine proteomics: the present and future of measuring urinary protein components in disease
Jonathan Barratt et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Recent progress in urinary proteomics
Visith Thongboonkerd
PROTEOMICS CLINICAL APPLICATIONS (2007)
分享论文
